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Association of Age-Related Hearing LossWith Cognitive
Function, Cognitive Impairment, and Dementia
A Systematic Review andMeta-analysis
David G. Loughrey, BA(Hons); Michelle E. Kelly, DPsychBAT; George A. Kelley, DA; Sabina Brennan, PhD;
Brian A. Lawlor, MD, FRCPI, FRCPsych
IMPORTANCE Epidemiologic research on the possible link between age-related hearing loss
(ARHL) and cognitive decline and dementia has produced inconsistent results. Clarifying this
association is of interest because ARHLmay be a risk factor for outcomes of clinical dementia.
OBJECTIVES To examine and estimate the association between ARHL and cognitive function,
cognitive impairment, and dementia through a systematic review andmeta-analysis.
DATA SOURCES AND STUDY SELECTION A search of PubMed, the Cochrane Library, EMBASE,
and SCOPUS from inception to April 15, 2016, with cross-referencing of retrieved studies and
personal files for potentially eligible studies was performed. Keywords included hearing,
cognition, dementia, and Alzheimer disease. Cohort and cross-sectional studies published in
peer-reviewed literature and using objective outcomemeasures were included. Case-control
studies were excluded.
DATA EXTRACTION AND SYNTHESIS One reviewer extracted and another verified data. Both
reviewers independently assessed study quality. Estimates were pooled using random-effects
meta-analysis. Subgroup andmeta-regression analyses of study-level characteristics were
performed.
MAIN OUTCOMES ANDMEASURES Hearing lossmeasured by pure-tone audiometry only and
objective assessment measures of cognitive function, cognitive impairment, and dementia.
Cognitive function outcomes were converted to correlation coefficients (r value); cognitive
impairment and dementia outcomes, to odds ratios (ORs).
RESULTS Forty studies from 12 countries met our inclusion criteria. Of these, 36 unique
studies with an estimated 20 264 unique participants were included in themeta-analyses.
Based on the pooledmaximally adjusted effect sizes using random-effects models, a small
but significant association was found for ARHLwithin all domains of cognitive function.
Among cross-sectional studies, a significant association was found for cognitive impairment
(OR, 2.00; 95% CI, 1.39-2.89) and dementia (OR, 2.42; 95% CI, 1.24-4.72). Among
prospective cohort studies, a significant association was found for cognitive impairment (OR,
1.22; 95% CI, 1.09-1.36) and dementia (OR, 1.28; 95% CI, 1.02-1.59) but not for Alzheimer
disease (OR, 1.69; 95% CI, 0.72-4.00). In further analyses, study, demographic, audiometric,
and analyses factors were associated with cognitive function. Vascular dysfunction and
impaired verbal communicationmay contribute to the association between hearing loss and
cognitive decline.
CONCLUSIONS AND RELEVANCE Age-related hearing loss is a possible biomarker and
modifiable risk factor for cognitive decline, cognitive impairment, and dementia. Additional
research and randomized clinical trials are warranted to examine implications of treatment for
cognition and to explore possible causal mechanisms underlying this relationship.
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D ementia affects an estimated 46.8 million personsworldwide and is projected to affect approximately131.5million in2050withanestimatedcost ofUS$818
billion in 2015 and US $2 trillion by 2050.1 Current pharma-
ceutical approaches targetingneuropathologicprocesses such
asAlzheimerdisease (AD)offer limitedbenefitwith symptom-
modifying effects at best.2 Switching to a preventive strategy
through reduction of risk factorsmaybemore beneficial than
pharmacologic therapyafter clinical expressionofneuropatho-
logic changes3 and may lead to significant reductions in
medical costs.4
Approximately one-third of adults older than65 years ex-
periencesadisablinghearing loss.5Cohort studies indicate that
age-related hearing loss (ARHL) precedes the onset of clinical
dementia by 5 to 10 years, is a possible noninvasive bio-
marker, andmayoffer apathway tomodify clinical outcomes.6
As an emerging risk factor, a limited number of studies have
examined ARHL and cognitive decline. Epidemiologic find-
ings have been inconsistent possibly owing to suboptimal
methods (eg, self-reportedhearing loss or cognitive testswith
auditory stimuli).7 Prior reviews8-10 havenot includedameta-
analysis or have included different measures of hearing im-
pairment and studies of different designs.
We conducted a systematic review and meta-analysis to
investigate and quantify the association between ARHL and
cognitive function, cognitive impairment, and dementia. We
reduced conceptual heterogeneity by includingonly observa-
tional cross-sectional and cohort studies that assessed hear-
ing loss using pure-tone audiometry (the criterion standard).
We conducted exploratory subgroup and meta-regression
analyses to examine possible explanations for heterogeneity
owing to demographic, study, health, and analysis factors.
Methods
This systematic reviewwasperformedaccording to anapriori
establishedprotocol. It adhered to thePrimaryReporting Items
for Systematic Reviews and Meta-analyses (PRISMA)
Statement11 andmet theMeta-analysis ofObservational Stud-
ies in Epidemiology (MOOSE) guidelines.12 All analyses were
conductedusingComprehensiveMeta-Analysis software (ver-
sion 3; Biostat). Institutional review board approval and in-
formed consent were not required for this systematic review
andmeta-analysis.
Search Strategy and Selection Criteria
Sixapriorimeta-analyseswereplannedacross2 levelsof study
design(cross-sectionalandcohort)and3levelsofoutcome(cog-
nitive function, cognitive impairment, and dementia). The in-
clusioncriteria consistedof (1) cross-sectional andcohort stud-
ies, excluding case-control studies because of greater concern
about sampling and retrospective analysis bias13 (all study de-
signshaveselectedtypesofbias); (2)publishedstudies (any lan-
guage); (3) study sample 18 years or older; (4) baseline sample
including the general, community-dwelling population rather
than special risk groups (eg, patients with coronary heart dis-
ease); (5) individual’s peripheral hearing status (as assessed by
pure-toneaudiometric assessment) as themainexposurevari-
able; (6) full inclusion of hearing loss sample (ie, no pure-tone
audiometric cutoff); (7) assessment of cognitive function, cog-
nitive impairment,14 and/or dementia as outcome(s); and (8)
exposure andoutcomemeasurements obtainedbyhealth care
professionals or trained investigators (ie, not based on self-
reported data).
Studies published on or before August 26, 2015, were re-
trieved from the following4 electronic databases by one of us
(D.G.L.): (1) PubMed, (2) theCochraneLibrary, (3)EMBASE,and
(4) SCOPUS. Keywords included hearing, cognition, demen-
tia, and Alzheimer disease (eTable 1 in the Supplement). Re-
sultswereupdatedonApril 15, 2016.Cross-referencing forpo-
tentiallyeligible studieswasconductedusing retrievedstudies
and personal files belonging to one of us (D.G.L.).
Data Extraction andQuality Assessment
Twoof us (D.G.L. andM.E.K.) independently screened for eli-
gible studiesandconducteddataextraction. If consensuscould
not be reached, another of us (B.A.L.) acted as arbitrator for
study inclusion, and another (G.E.K.) was consulted regard-
ingdata extraction.Cognitive functionwas subdivided into 10
domains, including episodic memory (delayed recall and im-
mediate recall), executive functions (attention, fluency, rea-
soning, and working memory), global cognition, processing
speed, semanticmemory, andvisuospatial ability.15Amongde-
mentia studies, a secondary outcomeof interestwas anydata
that examined subgroups (eg, AD).
Data from the most recently published study were se-
lected.Data fromdifferent studies that examined the sameco-
hort were included if they were for different cognitive out-
comesandwere treatedas separate studies inanalysis. Priority
was given to outcomes that were maximally adjusted for co-
variates. Two of us (D.G.L. and M.E.K.) independently as-
sessed the quality of reporting for each study using the
Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) instrument.16 With use of the Cohen κ
coefficient,17 agreement was excellent (κ = 0.91) before cor-
recting discrepant items.
Statistical Analysis
Wechose thePearson r correlationcoefficient as theeffect size
of the linear association between hearing loss and cognitive
Key Points
Question Is age-related hearing loss associated with an increased
risk for cognitive decline, cognitive impairment, and dementia?
Findings In this systematic review andmeta-analysis of 36
epidemiologic studies and 20 264 unique participants, age-related
hearing loss was significantly associated with decline in all main
cognitive domains and with increased risk for cognitive
impairment and incident dementia. Increased risks for Alzheimer
disease and vascular dementia were nonsignificant.
Meaning Age-related hearing loss is a possible biomarker and
modifiable risk factor for cognitive decline, cognitive impairment,
and dementia.
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function (continuousvariables).Negative scores indicated that
greaterhearing losswasassociatedwithpoorercognition.Odds
ratios (ORs) were chosen for cognitive impairment and de-
mentia (categorical variables). Influence of various audiom-
etric criteria (eg, worse vs better ear) and cognitive tests (vi-
sual vs auditory stimuli) on outcome were examined in
subgroupanalyses. If the requiredoutcomemetricwasnot re-
ported in thestudy,valueswerecalculatedusingavailabledata.
Random-effects, method-of-moments models that incorpo-
rate heterogeneity into the overall estimatewere used to pool
effect sizes from each study.18 All outcomes were converted
to Fisher z values or logarithmORs for analysis purposes and
then convertedback to theoriginalmetric (ie, r correlation co-
efficient andOR, respectively). For bothmeta-analysesof cog-
nitive function, multiple tests of the same cognitive domain
from the same study were collapsed into a single effect size
andwithin-study subgroupswere analyzed independently as
separate effect sizes.
Heterogeneitywas examinedusing theQ test, andP ≤ .10
was considered to be statistically significant.19 Inconsistency
was examined using the I2 statistic, and the following
grades were applied: less than 25% indicated very low; 25%
to less than 50%, low; 50% to less than 75%, moderate; and
75% or greater, large.19 Small-study effects were examined
using funnel plots, and the regression-intercept approach of
Egger and colleagues20 provided at least 10 effect sizes were
present. To examine the influence of each result on the
overall findings, outcomes were analyzed by deleting each
study from the model once. Cumulative meta-analysis
ranked by year was used to examine the accumulation of
evidence over time.21
We conducted subgroup and meta-regression analyses to
examineheterogeneity between studies. Plannedvariables in-
cluded (1) study characteristics, (2) participant characteristics,
(3) audiometric factors, (4) cognitive measures, and (5) statis-
tical analysis (eTable2 in theSupplementprovidesa listof each
planned variable). For continuous variables,we used random-
effects meta-regression22 where at least 4 effect sizes were
found. For categorical variables,we examined between-group
differences (between-groupQvalue) ineffect sizesusingmixed
effects analysis of variance–like models for meta-analysis22 if
at least 3 effect sizes were available for each category. These
analyses were considered to be exploratory.
Results
Characteristics and Quality of Included Studies
The characteristics of included studies are shown in eTable 3
in the Supplement. Of the 1185 citations reviewed, 40
studies7,23-61met the inclusioncriteria, representing34471par-
ticipants from12countries (Figure 1).Of these, 36unique stud-
ies with an estimated 20 264 unique participants were in-
cluded in themeta-analyses. Study quality results are shown
in Table 1 and Table 2 and eFigure 1 in the Supplement. Fur-
ther details on themain analyses are found in eFigures 2 to 27
and eTables 3 to 9 in the Supplement; and further details on
thesmall-study, influence,andcumulativeanalyses, in theeRe-
sults and eFigures 28 to 74 in the Supplement. Thirty-five of
the 40 included studies (88%) met the criteria for at least 16
of 22 STROBE items. Further details on themain analyses and
descriptions of the small-study, influence, and cumulative
analyses are found in eFigures 2 to 27 and eTables 3 to 9 in the
Supplement. Diagnostic criteria for each clinical outcome are
shown in the Table 1 and Table 2.
Twenty-six studies with 15 620 participants were in-
cluded in the cross-sectional cognitive function analysis.23-48
Twostudieswereomittedbecauseofduplicatedata.49,50Nine
studies with 8233 participants7,29,36,40,46,48,51-53 were in-
cluded in the cohort cognitive function analysis with a fol-
low-up ranging from2 to23years (mean [SD], 10.4 [6.7] years).
Five studies with 6582 participants (797 cases of 6553
included participants [12.2%])30,55-58 were included in the
cross-sectional cognitive impairment analysis. Two studies
wereomittedbecauseofduplicatedata.54,59Threestudieswith
7817 participants (1395 cases of 6825 included participants
[20.4%]) were included in the cohort cognitive impairment
analysiswitha follow-upranging from6to18years (mean[SD],
11.7 [6.0] years).7,40,55
Figure 1. PRISMA FlowDiagram
1824 Records identified through
database search
1273 SCOPUS
504 PubMed
32 Cochrane Library
15 EMBASE
155 Full-text articles assessed for eligibility
40 Studies included in qualitative synthesis
36 Studies included in quantitative synthesis (meta-analysis)
26 Cross-sectional cognition
9 Cohort cognition
5 Cross-sectional impairment
3 Cohort impairment
3 Cohort dementia
2 Cross-sectional dementia
57 Additional records identified
through other sources
1185 Records screened after duplicates removed
1030 Records excluded
888 Off topic
105 Inappropriate design,
outcomes, or population
37 Review
115 Full-text articles excluded
43 No audiometry
31 Case-control
19 Inappropriate sample
12 Inappropriate audiometric
criteria
7 No statistical analysis
2 Inappropriate design
1 Audiometric assessment
not specified
Study selection for themeta-analysis. Some studies were allocated tomore
than 1 category.
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Two studies with 741 participants (59 cases of 679 in-
cluded participants [8.7%])58,60 were included in the cross-
sectional dementia analysis.One studyassesseddementia (39
casesof 245 includedparticipants [15.9%]),60 and theother as-
sessed AD (20 cases of 434 included participants [4.6%]).58
Three studies with 3585 participants7,29,61 (10.4%) were in-
cluded in thecohortdementia analysiswitha follow-up length
ranging from 9 to 18 years (mean [SD], 15.0 [5.2] years). All 3
studies reported incident dementia outcomes (366 cases of
3439 included participants [10.6%]), 2 examined an AD sub-
set (78 cases of 1491 includedparticipants [5.2%]),7,61 and 1 ex-
amined a vascular dementia subset (38 cases of 870 included
participants [4.4%]).7
Hearing Loss and Cognitive Function
We found a small but statistically significant association be-
tween ARHL and all 10 cognitive domains of interest in cross-
sectional studies, includingglobal cognition (r = −0.15;95%CI,
−0.18 to −0.11), executive functions (range, r = −0.08 [95%CI,
−0.12 to −0.04] to r = −0.18 [95% CI, −0.25 to −0.10), episodic
memory (range, r = −0.10 [95%CI, −0.16 to −0.04] to r = −0.14
[95%CI, –0.20 to –0.09]), processing speed (r = −0.13; 95%CI,
–0.18 to 0.08), semantic memory (r = −0.14; 95% CI, –0.20 to
–0.08),andvisuospatialability (r = −0.11;95%CI,–0.19to–0.03).
Similar resultswere observed in 7 of 8 domains in cohort stud-
ies,excludingfluency,whichwasnotsignificant (r = −0.07;95%
CI, –0.14 to 0.01). These results included global cognition
(r = −0.14; 95%CI, –0.19 to –0.09), executive functions (range,
r = −0.06 [95%CI, –0.12 to –0.004] to r = −0.10 [95%CI, –0.20
to –0.001]), episodicmemory (range, r = −0.06 [95% CI, –0.10
to–0.02] to r = −0.10 [95%CI, –0.15 to –0.05), processing speed
(r = −0.08; 95% CI, –0.14 to –0.03), and semantic memory
(r = −0.14;95%CI, –0.23 to –0.05) (Figure2,Figure3, andeFig-
ures 10-27 and eTables 1-9 in the Supplement). No cohort data
were available for visuospatial ability or working memory.
Heterogeneity was significant in most domains (Q range, 0.0-
79.9). Inconsistency ranged from very low to high.
Hearing Loss and Cognitive Impairment
Wefounda statistically significant associationbetweenARHL
andcognitive impairmentacrosscross-sectional (OR,2.00;95%
CI, 1.39-2.89) and cohort studies (OR, 1.22; 95% CI, 1.09-1.36)
(eFigures 2 and 3 and eTable 7 in the Supplement). Statisti-
cally significant heterogeneity (Q range, 0.1-23.7) and a large
amountof inconsistencywereobserved in cross-sectional but
not in cohort studies.
Hearing Loss and Dementia
Wefounda significant associationbetweenARHLanddemen-
tia in cross-sectional (OR, 2.42; 95%CI, 1.24-4.72) and cohort
(OR, 1.28; 95%CI, 1.02-1.59) studies (eFigures 4-9 and eTable
7 in theSupplement). Statistically significantheterogeneity (Q
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range, 0.4-6.6) and amoderate amount of inconsistencywere
observed in cohort but not cross-sectional studies. No statis-
tically significant association was found between ARHL and
AD for cross-sectional (OR, 1.80; 95%CI, 0.58-5.60) or cohort
(OR, 1.69; 95% CI, 0.72-4.00) studies. In addition, the asso-
ciationbetweenARHLandvascular dementiawasnot signifi-
cant (OR, 2.40; 95% CI, 0.99-5.82).
Subgroup Analyses andMeta-regression
The results of the subgroup andmeta-regression analyses for
cognitive outcomes are summarized below (eTables 8 and 9
in the Supplement). The respective Fisher z values (modera-
toranalysis), slope (meta-regression), SEs, and95%CIs foreach
variable are available in eTables 10 to 36 in the Supplement.
Study Characteristics
Studies conducted in theUnited States reportedweaker asso-
ciations betweenARHLand cognition comparedwithAustra-
lian and European studies, possibly owing to differences in
prevalence of ARHLor cognitive decline and dementia. Asso-
ciations generally becameweakerwith later publicationdates
(possibly owing to increased adjustment for covariates) and,
in some cases, with higher STROBE score. Results for journal
impact factor were mixed. Among cohort studies, results for
length of follow-up were mostly insignificant.
Participant Characteristics
Cross-sectional associations were weaker when studies ex-
cluded participantswith cognitive impairment and dementia
and included participants with cardiovascular risk. Associa-
tionswith cohort processing speedweremixedwith regard to
whether participants with cognitive impairment were re-
movedatbaselineor in analysis. Theageandsexof the sample
generallyhadmixedresults.Associationswereweaker forstud-
ies with mixed-race participants compared with studies in
which the breakdown by race was not declared. Associations
were typically strongerwith an increasedproportion ofwhite
participants but weaker with black participants and nonsig-
nificant for those of other races, possibly owing to selective
survival. Associationswere also typically strongerwith an in-
creasedproportionofprimaryeducational attainment,weaker
with tertiary educational attainment, andmixedwith second-
ary educational attainment and mean years of education.
Smoking (current andprevious) had a significant association.
Audiometric Factors
Stronger associations were usually found for lower-
frequency hearing loss (<4 kHz) and when auditory function
was assessed with both ears (compared with only the better
ear). No significant difference was found for hearing loss ex-
amined as a categorical (>25 dB) vs a continuous variable.
Weaker associationswere generally foundwhen studies used
a sound-treated room or booth or followed the World Health
Organization criteria.62 Declared inclusion of hearing aid us-
ersweakened theassociation for immediate recall and seman-
tic memory. However, the proportion of hearing aid users in-
cluded inthestudyhadnosignificant result.Thesampledegree
of hearing loss significantly weakened the association with
cross-sectional attention and immediate recall. The propor-
tion of individuals diagnosed with hearing loss by study au-
thors weakened the association with immediate recall. Re-
sults were otherwise mixed and nonsignificant.
CognitiveMeasures
Results were mostly minor and inconsistent with respect to
whether thecognitive testwasaccessible toasamplewithhear-
ing loss. The only significant result found a stronger associa-
tion for nonbiased tests.
Statistical Analysis
Astrongerassociationwasgenerally foundforstudies thatused
correlation as the statistical model (compared with linear re-
gression or linear mixed models) and those that reported re-
sults as significant. Studies that used age, sex, race, educa-
tional attainment, and vascular factors as covariates in their
analysis typically reported weaker (sometimes significantly
weaker) associations. This same trendwas observed for stud-
ies that controlled for stroke, hypertension, diabetes, and cur-
rent or previous smoking. Controlling for depression signifi-
cantlyweakenedtheassociationwithcross-sectionalattention.
Results for premorbid IQ were mixed and nonsignificant ex-
cept for cohort global cognition.
Because of a lack of data, no other a priori variables were
examined. Other variables were reviewed ad hoc. A signifi-
cantlyweakerassociationwasgenerally foundforanalyses that
controlled for study site. These analyses were not conducted
forcognitive impairmentanddementiaoutcomesowingto lack
of studies,with the exceptionof cross-sectional cognitive im-
pairment studies. Year of publication, age (mean and mini-
mum), sex, sample degree of hearing loss, proportion with
hearing loss and cognitive impairment, impact factor, and
STROBEwere assessed (eTable 37 in the Supplement). No as-
sociation was statistically significant.
Discussion
Inthismeta-analysis,ARHLhadsignificantassociationswithac-
celeratedmultidomaincognitivedecline,cognitive impairment,
and dementia, thus supporting further consideration of ARHL
asarisk factor for theseoutcomes.3,6Theassociations,although
small,werecomparable insizeandsignificancewithothermore
commonly researched risk factors usingmeta-analysis.3
The result for AD indicated increased risk with ARHL but
wasnonsignificant,most likely owing to small sample sizes or
to causal factors other than AD etiology underpinning the
association.6Age-relatedhearing losshasbeenassociatedwith
increased global and regional gray matter atrophy and white
matterhyperintensities,whereasADsubstratehasbeen found
in the auditory neural regions but not in the peripheral audi-
tory structures.63
Studyquality assessment showed that reportingwas gen-
erallyofverygoodquality. Poor reportingof attrition ratesmay
conceal a greater decline in cognition and risk for dementia in
older cohorts owing to higher numbers of dropouts among
thosewithpoorer health. Subgroup analysis foundnobias for
Age-Related Hearing Loss, Cognitive Function, and Dementia Original Investigation Research
jamaotolaryngology.com (Reprinted) JAMAOtolaryngology–Head&Neck Surgery February 2018 Volume 144, Number 2 123
© 2017 American Medical Association. All rights reserved.
Downloaded From: https://jamanetwork.com/ by a Maynooth University User  on 11/04/2019
verbal or audio cognitive tests. However, some potential bias
mayhaveexistedbecausea strongereffect sizewas foundwith
substandard audiometric assessment.
Causal Mechanisms for ARHL and Cognitive Decline
The association between ARHL and cognitive decline re-
mains unclear.61 One hypothesis is a common etiology, such
asdecline in thevascular systemorabroaderphysiological de-
cline. Age-related hearing loss has been linked with multiple
indicators of functional decline and is a biomarker for frailty
syndrome,whichhasbeencausally linkedtodementia.64Other
hypotheses suggest that the associationmay bemechanistic,
for example, ARHL causing cognitive decline through im-
paired speech perception.61
Vascular risk factors contributed significantly to decline
inglobal cognitionandprocessing speed.However, thepooled
effect sizeof studiescontrolling forvascular risk factors in these
outcomes remained significant, suggesting other contribut-
ing factors, for example, depression,which significantlymod-
erated the association with attention.
Of interest, thepatternofdeclineobserved inthisstudywas
consistentwithestimatedcognitiveoutcomesbasedonbehav-
ioral and neuroimaging research.65 This research reports in-
creasedrecruitmentof short-termmemoryandexecutive func-
tions to aid speech perception after acquired hearing loss and
concomitant decline in auditory cortex regions.66 This situa-
tion is estimated to lead to less decline in these functions but
greaterdecline inepisodicandsemantic long-termmemoryow-
ing to reallocationofcognitive resources.65Consistentwith this
research,weobservedthathearing losswas lessassociatedwith
decline in executive functions and immediate recall compared
with delayed and semantic memory andwas increasingly less
predictive of decline in attention and immediate recall among
thosewithgreaterhearing loss. In addition, semanticmemory,
usually maintained in older age compared with episodic
memory,67 demonstrated a decline similar to that of episodic
memory. Furthermore, the results indicated that hearing aids
may benefit short-term and semantic memory.
Thestrongerassociationfor low-tomiddle-frequencyhear-
ing loss with immediate recall and processing speed may be
attributable to advanced aging as ARHL progresses fromhigh
to lowfrequencies.64Of interest,vasculardysfunctionhasbeen
associatedwith lower-frequency hearing loss andwhitemat-
ter hyperintensities.68 Alternatively, reallocation of execu-
tive functions to support accuracy in speech perception may
be associated with decline in performance speed, as also ob-
served in older adults with visual processing deficits.69
Future Directions
Cognitive decline is influenced by multiple modifiable health
factors.3Hearing lossmaybeanotherserviceable risk factor,be-
cause it is easily diagnosed and can be treated.70 Although as-
sociationsweresmall, treatmentmaycumulativelybenefit cog-
nitionasobservedininterventionstudies inolderadultswithout
cognitive impairment.71-73 Thisbenefitwasnotobserved inpa-
tientswithdementia,but treatmentmaystill reducedisability.74
Decline in lexical or semantic, episodic memory, and execu-
tive functions is used by clinicians as amarker for probableAD
and vascular dementia.75 In patients with ARHL, these do-
mains may benefit from improved verbal communication
throughuseofhearingaids.Additionalrandomizedclinical trials
exploring the cognitive benefits of hearing loss treatment are
required, as ismore research as towhether treatment, aloneor
as part of a wider approach to risk factors, modifies dementia
outcomes. Neuroimaging studies could examinemodification
ofcorticalchangesandneurocognitivecompensationwithhear-
ingaiduse inspeechtasks.Futureepidemiologic researchmight
assess whether ARHL is associated with cognitive decline in-
dependently of neuropathologic hallmarks of dementia and
whether a mediator of this association exists (eg, loneliness).
Alsoof interestwouldbewhether cognitive reservemoderates
cognitive decline in the populationwith ARHL. Our results in-
dicated amoderator effect of educational attainment,which is
often used as a proxy for cognitive reserve.76
Increasingevidence suggests thatARHL is associatedwith
a wide range of health issues, higher disease burden, and in-
creased risk for hospitalization,64,77 leading to greater aware-
ness of this condition as a critical public health concern.70,77
In theUnited States, only 1 in 5 adultswith hearing losswears
hearing aids, possibly owing to cost, lack of insurance cover-
age, or lack of knowledge of health care options, particularly
for milder loss.70 The National Academies of Sciences, Engi-
neering, and Medicine recently outlined several recommen-
dations toaddress this issue,with implications forpublichealth
services and policy.70,78 Initiatives to expand access to treat-
ment through screening programs, expand delivery of hear-
ing services, and provide coverage for assistive hearing de-
vices would be beneficial.70 In addition, primary health care
clinicianswould benefit from standard guidelines for screen-
ing and referring patients with hearing loss.70
Strengths and Limitations
To the our knowledge, this study is the first systematic re-
view and meta-analysis of ARHL and cognitive decline that
usedonlypure-tone thresholdsas theaudiometric criteria.Our
strict inclusion criteria in study design and measurement al-
lowed us to reduce conceptual heterogeneity and thus pro-
vide the most accurate quantitative measure of this associa-
tion. Considerable heterogeneity remained across most
outcomes.However, in anyadjustedestimateof effect size for
risk factors derived from aging studies, residual confounding
will exist. Extensive subgroup and meta-regression analyses
investigating this heterogeneity provided insight intohow fu-
ture studies may reduce bias and explore the potential basis
of this association in experimental and clinical trials.
This study has several limitations.We could not examine
whether studies controlled foretiologyofhearing loss (eg, con-
genital or prelingual deafness). However, because of the low
prevalence (<2%) of hearing loss in patients younger than 40
years, this prevalence was considered to be insignificant.77
Some of the meta-analyses had a low number of effect sizes.
We could not examine other planned moderators and covar-
iates, such as attrition, owing to lack of data. For meta-
analyses of dementia subgroups, the number of cases was
small. Furthermore, because the meta-analyses were of ob-
servational studies, support for any inferences regarding the
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causal nature of the association is limited and cannot provide
direct evidence for policy recommendations. However, our
analyses of prospective studies give an indication of the tem-
poral order of the association consistent with a causal effect.
Further research is required todeterminewhether a causal re-
lationship exists.Owing to the largenumberof statistical tests
conducted, some of our findings could have been the result
of chance. However, we did not want to risk missing poten-
tially important findings that could be tested in future origi-
nal studies.Finally, as is thecasewithanyaggregatedatameta-
analysis, the potential for ecological fallacy exists.
Conclusions
Age-related hearing loss is a potential risk factor for cognitive
decline, cognitive impairment, anddementia. The effect sizes
for all 3 main outcomes were small, but they compared with
meta-analytic estimates for other risk factors more com-
monly investigated in thispopulation.Additional research,par-
ticularly randomized clinical trials, is warranted to examine
cognitive implications of treatment and to explore the pos-
sible causal mechanisms underlying this relationship.
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